# PTPN12

## Overview
PTPN12 is a gene that encodes the protein tyrosine phosphatase non-receptor type 12, commonly referred to as PTP-PEST. This protein is a member of the protein tyrosine phosphatase (PTP) family, which is characterized by its role in dephosphorylating tyrosine residues on target proteins, thereby modulating various signaling pathways. PTP-PEST is involved in critical cellular processes, including cell adhesion, motility, and migration, and is particularly abundant in hemopoietic and epithelial cells (Hendriks2013Protein). It plays a significant role in the immune system by regulating T-cell and B-cell receptor signaling, and in skeletal development by influencing osteoclast function (Schiller2005Tyrosine). The protein's activity is tightly regulated through post-translational modifications, which affect its interactions with other cellular components and its role in signaling pathways. PTPN12 has been implicated in various cancers, where its altered expression or mutation can contribute to tumorigenesis and metastasis, highlighting its potential as a therapeutic target (Huo2020Progress; Lan2023PTPN12).

## Structure
PTPN12 is a protein tyrosine phosphatase that plays a significant role in cellular signaling. The protein contains a catalytic domain typical of protein tyrosine phosphatases (PTPs), which is characterized by a conserved cysteine residue essential for its enzymatic activity. This cysteine residue is crucial for the catalytic mechanism, as it participates directly in the dephosphorylation process. The structure of PTPN12 may include secondary structural elements such as alpha-helices and beta-sheets, which contribute to its overall tertiary structure. These structural features are important for maintaining the protein's stability and functional conformation.

PTPN12 can undergo post-translational modifications, such as phosphorylation, which can influence its function and activity. These modifications may affect the protein's interaction with other cellular components and its role in signaling pathways. The presence of such modifications suggests that PTPN12's activity is tightly regulated within the cell, allowing it to respond to various cellular signals and conditions. The specific details of PTPN12's quaternary structure, such as potential interactions with other proteins or formation of multimeric complexes, are not provided in the available context.

## Function
PTPN12 encodes the protein tyrosine phosphatase PTP-PEST, which is involved in several critical cellular processes. This protein is highly abundant in hemopoietic and epithelial cells and plays a significant role in regulating cell adhesion, motility, and migration by interacting with or dephosphorylating adapter, signaling, and cytoskeletal proteins (Hendriks2013Protein). In the immune system, PTP-PEST negatively regulates T-cell receptor (TCR) and B-cell receptor (BCR) signaling, which is essential for maintaining normal immune responses (Hendriks2013Protein).

PTP-PEST is also involved in the regulation of podosome formation in osteoclasts, which are cells responsible for bone resorption. It is associated with the assembly and disassembly of podosomes, specialized structures crucial for osteoclast motility and function. The phosphorylation state of PTP-PEST, influenced by factors such as osteopontin, affects its activity and the stability of the podosome complex, thereby impacting cell migration and bone resorption processes (Schiller2005Tyrosine).

Overall, PTPN12 plays a multifaceted role in cellular signaling and structural dynamics, influencing both immune function and skeletal development through its phosphatase activity.

## Clinical Significance
Mutations and alterations in the expression of the PTPN12 gene have significant clinical implications in various cancers. In breast cancer, particularly triple-negative breast cancer (TNBC), PTPN12 is often inactivated, leading to enhanced tumorigenicity and metastasis. Restoring PTPN12 expression in TNBC can inhibit these processes, highlighting its potential as a therapeutic target (Sarmasti2024Identification; Huo2020Progress). In colorectal cancer, a specific missense variant, PTPN12 rs3750050, is associated with an increased risk, as it impairs the gene's ability to inhibit the Ras/MEK/ERK signaling pathway, contributing to abnormal cell proliferation (Shen2019A).

In non-small cell lung cancer (NSCLC), lower PTPN12 expression is linked to poorer survival outcomes, while in nasopharyngeal carcinoma, decreased expression correlates with larger tumor size and metastasis (Huo2020Progress). In ovarian cancer, PTPN12 is negatively regulated by miR-194, promoting cancer progression (Huo2020Progress). Additionally, in laryngeal squamous cell carcinoma, PTPN12 downregulation by miR-146b-3p contributes to increased cell proliferation and invasion (Lan2023PTPN12).

PTPN12 also plays a role in hereditary leiomyomatosis and renal cell carcinoma (HLRCC), where its oxidation leads to ABL1 hyperphosphorylation, promoting tumor growth (Xu2018Pathologic). These findings underscore the gene's importance as a tumor suppressor and its potential as a biomarker and therapeutic target in cancer treatment.

## Interactions
PTPN12, also known as protein tyrosine phosphatase non-receptor type 12, is involved in numerous protein interactions that regulate various cellular processes. It interacts with the adaptor protein Crk-associated substrate (Cas) and its relatives Sin and CasL through its P1 motif, and with the LIM domains of paxillin, Hic-5, leupaxin, protein tyrosine kinase 2 (Pyk2), and focal adhesion kinase (FAK) via the P2 motif (Lee2019Important). PTPN12 also associates with the SH3 domains of Grb2 through its P1, P3, P4, and CTH domains, and with the inhibitory PTK, C-terminal Src kinase (Csk) via the P4 motif (Lee2019Important). 

PTPN12 interacts with the phosphotyrosine binding (PTB) domain of Shc through an NPLH sequence, and its CTH domain binds to scaffold proteins PSTPIP1 and PSTPIP2, which are involved in cytoskeletal regulation (Lee2019Important). In endothelial cells, PTPN12 interacts with the catalytic subunits of 5'-AMP-activated protein kinase (AMPK), specifically AMPKα1 and α2, under normoxic conditions (Chandel2020Protein). 

In glioblastoma cells, PTPN12 interacts with valosin-containing protein (VCP), influencing the phosphorylation-dependent ubiquitination and stability of focal adhesion substrates (Chen2018PTPN12PTPPEST). These interactions highlight PTPN12's role in modulating cell adhesion, migration, and signaling pathways.


## References


[1. (Hendriks2013Protein) Wiljan J.A.J. Hendriks and Rafael Pulido. Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832(10):1673–1696, October 2013. URL: http://dx.doi.org/10.1016/j.bbadis.2013.05.022, doi:10.1016/j.bbadis.2013.05.022. This article has 85 citations.](https://doi.org/10.1016/j.bbadis.2013.05.022)

[2. (Chandel2020Protein) Shivam Chandel, Amrutha Manikandan, Nikunj Mehta, Abel Arul Nathan, Rakesh Kumar Tiwari, Samar Bhallabha Mohapatra, Mahesh Chandran, Abdul Jaleel, Narayanan Manoj, and Madhulika Dixit. Protein tyrosine phosphatase-pest mediates hypoxia-induced endothelial autophagy and angiogenesis via ampk activation. Journal of Cell Science, January 2020. URL: http://dx.doi.org/10.1242/jcs.250274, doi:10.1242/jcs.250274. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.250274)

[3. (Schiller2005Tyrosine) Katherine R. Schiller and Laura J. Mauro. Tyrosine phosphatases as regulators of skeletal development and metabolism. Journal of Cellular Biochemistry, 96(2):262–277, July 2005. URL: http://dx.doi.org/10.1002/jcb.20515, doi:10.1002/jcb.20515. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.20515)

[4. (Shen2019A) Na Shen, Lu Li, Wang Xu, Jianbo Tian, Yang Yang, Ying Zhu, Yajie Gong, Juntao Ke, Jing Gong, Jiang Chang, Rong Zhong, and Xiaoping Miao. A missense variant in ptpn12 associated with the risk of colorectal cancer by modifying ras/mek/erk signaling. Cancer Epidemiology, 59:109–114, April 2019. URL: http://dx.doi.org/10.1016/j.canep.2019.01.013, doi:10.1016/j.canep.2019.01.013. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canep.2019.01.013)

[5. (Sarmasti2024Identification) Sahar Sarmasti Emami, Anni Ge, Derek Zhang, Yawei Hao, Min Ling, Rachel Rubino, Christopher J. B. Nicol, Wenqi Wang, and Xiaolong Yang. Identification of ptpn12 phosphatase as a novel negative regulator of hippo pathway effectors yap/taz in breast cancer. International Journal of Molecular Sciences, 25(7):4064, April 2024. URL: http://dx.doi.org/10.3390/ijms25074064, doi:10.3390/ijms25074064. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25074064)

[6. (Lan2023PTPN12) Lili Lan, Huan Cao, Lei Zhao, Weina Cui, and Baoshan Wang. Ptpn12 down-regulated by mir-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma. Open Medicine, January 2023. URL: http://dx.doi.org/10.1515/med-2023-0727, doi:10.1515/med-2023-0727. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/med-2023-0727)

[7. (Huo2020Progress) Yu-hu Huo, Ya-ni Wang, Ling-bing Meng, Ai-li Zhang, and Bin Liu. Progress in the correlation between ptpn12 gene expression and human tumors. Medicine, 99(24):e20445, June 2020. URL: http://dx.doi.org/10.1097/md.0000000000020445, doi:10.1097/md.0000000000020445. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/md.0000000000020445)

[8. (Chen2018PTPN12PTPPEST) Zhihua Chen, John E. Morales, Paola A. Guerrero, Huandong Sun, and Joseph H. McCarty. Ptpn12/ptp-pest regulates phosphorylation-dependent ubiquitination and stability of focal adhesion substrates in invasive glioblastoma cells. Cancer Research, 78(14):3809–3822, July 2018. URL: http://dx.doi.org/10.1158/0008-5472.CAN-18-0085, doi:10.1158/0008-5472.can-18-0085. This article has 35 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-18-0085)

[9. (Lee2019Important) Chaelin Lee and Inmoo Rhee. Important roles of protein tyrosine phosphatase ptpn12 in tumor progression. Pharmacological Research, 144:73–78, June 2019. URL: http://dx.doi.org/10.1016/j.phrs.2019.04.011, doi:10.1016/j.phrs.2019.04.011. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.phrs.2019.04.011)

[10. (Xu2018Pathologic) Yang Xu, Paul Taylor, Joshua Andrade, Beatrix Ueberheide, Brian Shuch, Peter M. Glazer, Ranjit S. Bindra, Michael F. Moran, W. Marston Linehan, and Benjamin G. Neel. Pathologic oxidation of ptpn12 underlies abl1 phosphorylation in hereditary leiomyomatosis and renal cell carcinoma. Cancer Research, 78(23):6539–6548, December 2018. URL: http://dx.doi.org/10.1158/0008-5472.CAN-18-0901, doi:10.1158/0008-5472.can-18-0901. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-18-0901)